logo
ResearchBunny Logo
Abstract
This editorial discusses a study evaluating the efficacy of tegoprazan, a novel potassium-competitive acid blocker (P-CAB), compared to esomeprazole for improving nighttime GERD symptoms and sleep disturbances. The study found that tegoprazan showed faster improvement in nighttime heartburn compared to esomeprazole, suggesting it may be a more effective treatment option for nighttime reflux.
Publisher
Journal of Neurogastroenterology and Motility
Published On
Jan 01, 2023
Authors
Yonghoon Choi, Cheol Min Shin
Tags
tegoprazan
potassium-competitive acid blocker
GERD
nighttime symptoms
esomeprazole
sleep disturbances
treatment efficacy
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs—just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny